Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients

Clin Transl Oncol. 2013 Apr;15(4):331-4. doi: 10.1007/s12094-012-0936-6. Epub 2012 Nov 10.

Abstract

Aim: This study was designed to explore the genetic polymorphism of IL-10 (-1082A/G, -592A/C, -819T/C), TNF-α (-308G/A) with susceptibility to docetaxel-induced liver injury (DILI) in Chinese breast cancer patients.

Methods: The targeted genetic polymorphisms of IL10-1082G/A, IL10-592A/C, IL10-819T/C, TNF-308G/A from 40 patients with DILI were assayed by matrix-assisted laser desorption/ionization-time of flight of Sequenom.

Results: AA genotype of IL10-592 and TT of IL10-819 significantly increased incidence of DILI (P = 0.005, OR = 3.137). No differences of TNF gene polymorphism between the two groups were seen.

Conclusion: The genetic polymorphism of the IL10-592A/C AA genotype and IL10-819T/C TT genotype was predominantly conferred to the incidence of docetaxel-induced liver injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Case-Control Studies
  • Chemical and Drug Induced Liver Injury / epidemiology
  • Chemical and Drug Induced Liver Injury / genetics*
  • Docetaxel
  • Female
  • Gene Frequency
  • Humans
  • Interleukin-10 / genetics*
  • Middle Aged
  • Polymorphism, Single Nucleotide / physiology
  • Taxoids / adverse effects*
  • Taxoids / therapeutic use
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Antineoplastic Agents
  • IL10 protein, human
  • Taxoids
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Docetaxel